art brain

Medicare launched a formal process that will determine whether the agency will cover Aduhelm, the newly approved Alzheimer's drug whose high price tag and unproven benefits have prompted widespread controversy.



from WebMD Health https://ift.tt/36xHGHf

Related Posts:

  • New Year, New You? Not So Fast... If you want a healthier 2019, it doesn’t have to be all or nothing. Make doable, achievable small changes, and you'll get the satisfaction of success and the motivation that comes with it. from WebMD Health https://wb.md/2… Read More
  • FDA Announces Safety Monitoring for Essure The FDA is implementing a number of steps for long-term safety monitoring of the permanent birth control device Essure, which will no longer be sold or distributed in the U.S. after Dec. 31, 2018. from WebMD Health https:/… Read More
  • Surgery Center May Have Infected Thousands After an investigation, a New Jersey outpatient surgery center is urging anyone treated there between Jan. 1 and Sept. 7, 2018, be tested for HIV and hepatitis B and C. from WebMD Health https://wb.md/2RnyUFE … Read More
  • Justice Ginsburg Out of Hospital After Surgery Justice Ruth Bader Ginsburg was released from the hospital Tuesday after lung cancer surgery, and is recovering a home, a Supreme Court spokeswoman says. from WebMD Health https://wb.md/2EOysd6 … Read More
  • Mad Cow Disease Diagnosed in Tennessee Man A 32-year-old Tennessee man has been diagnosed with the rare human form of mad cow disease, also known as Creutzfeldt-Jakob disease (CJD). from WebMD Health https://wb.md/2QO3rxc … Read More

0 comments:

Post a Comment

Popular Posts